• CLINICAL INTEREST SECTIONS: Coronary Peripheral TAVR Center

  • SCAI This Week
  • November 22, 2013

    In This Issue:

     


     

     


     

    Are You Prepared for Cardiology Coding Changes Coming in 2014?

    ENROLL NOW! On December 4, SCAI and ACC will host a webinar preparing you for the changes in cardiology coding coming in 2014. We will also revisit the new PCI code family that went into effect in 2013 to ensure everyone is up-to-speed and has a thorough understanding of the correct and intended use of this complex code family.   

    Plan now to attend this web-based educational program designed to keep you and your billing staff abreast of all the recent and new coding changes for cardiology services and procedures.   
    At this important webinar, you will learn directly from those who presented the codes and sat at the table during the CPT and RUC processes. Learn from our nationally known, leading CPT experts, Robert Piana, MD, FACC, and Art Lee, MD, FSCAI, who serve as the ACC and SCAI CPT Advisors, respectively, to the AMA CPT Editorial Panel.

    And don't miss this opportunity to hear the first-hand account and perspective of Srihari S. Naidu, MD, FSCAI, who serves as our clinical expert. Dr. Naidu will present our spotlight topic: "Forging a Pathway to Reimbursement: A First-Hand Look at the CPT and RUC Processes." Dr. Naidu will describe and take your questions about the impact the CPT Editorial and RUC Panels have on you and your practice, why your participation in the process is essential, and how the House of Cardiology bands together and engages others in our efforts to secure and protect the values for the services and procedures you provide to your patients

    FREE for SCAI Members — Register Now!

    Back to Top



    SCAI 2014: Top 5 Reasons to Submit Your Abstract(s)

    Abstract submissions are now being accepted for SCAI 2014 Scientific Sessions taking place May 28-31, 2014 in Las Vegas. Now in its 37th year, this program always draws the biggest names in Interventional and Invasive Cardiology.

    Here's your opportunity to be part of the Best of the Best in Interventional & Invasive Cardiology Education and for your research to be published in Interventional Cardiology's leading journal, Catheterization & Cardiovascular Interventions (CCI)!


    Abstract Submission Deadline: December 18, 2013


    Top 5 Reasons SCAI 2014 is the Ideal Forum for Your Research

    • Top 3 Abstracts receive “Best of the Best Abstract Awards”
    • Top 10 Abstracts selected for oral presentation
    • All presented abstracts will be published in Interventional Cardiology's leading journal, Catheterization and Cardiovascular Interventions (CCI)
    • FREE Registration to SCAI 2014 for Presenting Author (non-transferable)
    • Abstract Submission is FREE

    Submit your Abstract NOW!

    Register for SCAI 2014 NOW!

    Find Out More About SCAI 2014 Scientific Sessions

    Download the Preliminary Program

    Back to Top


    ACT NOW! SCAI Transradial Series Visits Phoenix on December 14

    Whether you are trying to pick up basic skill or looking for advanced techniques and best practices in transradial interventions, SCAI TRIP Phoenix is the course for you and your cardiac cath lab team! Taking place December 14, 2013, TRIP Co-chairs Samir B. Pancholy, MD, FSCAI and Sunil V. Rao, MD, FSCAI have designed a comprehensive one-day program for interventional and invasive cardiologists, interventional/invasive cardiology fellows-in-training, cath lab techs, and cath lab nurses.

    In addition to a dynamic mix of didactic lectures, case reviews, and one-on-one structured simulation training from the most highly trained and well respected experts in transradial interventions, SCAI TRIP Chicago offers a Nurse / Technician Breakout Session developed exclusively for cath lab nurses and technologists by Bernadette Speiser, BSN, MSN, CCRN.

    The Nurse/Tech Breakout Session will focus on:

    • Equipment Needs
    • Room Arrangements
    • Radial Artery Policy
    • TR Band Policy
    • TR Band Competency
    • Hemostasis Removal Documentation
    • Same-Day PCI
    • Education Requirement
    • Financial Investment / Savings

    Tuition Starts at Just $345 - Enroll Now!

    Additional Information on SCAI TRIP Phoenix

    Learn About Our Nurse / Tech Breakout Session

    Be Sure to Forward this Email to Your Cath Lab Team!

    Back to Top


    SCAI In the News: ERASE, CORAL, Medication Adherence

    During this week’s American Heart Association Scientific Sessions, SCAI leaders were interviewed by journalists about clinical trials including -  

    • CORAL: Cardiovascular Outcomes in Renal Atherosclerotic Lesions
    • ERASE:  Endovascular Revascularization and Supervised Exercise
    • A Text Messaging Intervention Improves Medication Adherence for Patients with Coronary Heart Disease

    Sample the coverage:

    For perspective on CORAL’s implications for clinical practice:

    Back to Top


    CCI: New Early View Content on Coronary Artery Disease

    In order to get critical information to members as soon as possible, SCAI's official journal, Catheterization & Cardiovascular Interventions (CCI), offers accepted manuscripts online in its Early View Section prior to inclusion of that manuscript in a print issue.

    The following Early View original studies and case reports in Coronary Artery Disease (CAD) have been made available online since November 1 - just log in at www.SCAI.org:

    Coronary Artery Disease

    Case Reports

     

    A novel technique for catheter engagement of protruding aorto-ostial stent
    Yoshiki Uehara, Mitsuyuki Shimizu and Michihiro Yoshimura
    ABSTRACT | Members CLICK HERE to Access Full Issue

     

    Fluoroscopy-guided snare retrieval of the celt ACD® metallic vascular closure device following failed deployment
    Thomas J. Cahill, Kiyoshi Choji and Attila Kardos
    ABSTRACT | Members CLICK HERE to Access Full Issue

     

    Transient right internal thoracic arterial graft kink related to respiratory movements: Documentation of its existence, relevance and proposed management
    Mathieu Pankert, Philippe L. L'Allier and Jean-Claude Tardif
    ABSTRACT | Members CLICK HERE to Access Full Issue

     

    Percutaneous retrieval of a twisted guide catheter using a longer second radial sheath Gregor Leibundgut, Nikolaus Löffelhardt and Franz-Josef Neumann
    ABSTRACT | Members CLICK HERE to Access Full Issue

    Letters to the Editor

     

    Change in donor artery fractional flow reserve after recanalization of a chronic total occlusion: Not as impressive as some might have us believe
    Andrew Ladwiniec and Angela dHoye
    ABSTRACT | Members CLICK HERE to Access Full Issue

    Original Studies

     

    Prevalence of obstructive coronary artery disease in patients undergoing lung transplantation: Case series and review of the literature
    Robert M. Jones, Kyle B. Enfield, Borna Mehrad and Ellen C. Keeley
    ABSTRACT | Members CLICK HERE to Access Full Issue

     

    Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: Insights from the PROTECT ΙΙ study
    Mauricio G. Cohen, Abhijit Ghatak, Neal S. Kleiman, Srihari S. Naidu, Joseph M. Massaro, Ajay J. Kirtane, Jeffrey Moses, E. Magnus Ohman, Vladimír Dzavík, Igor F. Palacios, Alan W. Heldman, Jeffrey J. Popma and William W. O'Neill
    ABSTRACT | Members CLICK HERE to Access Full Issue

     

    Functional and morphological assessment of side branch after left main coronary artery bifurcation stenting with cross-over technique
    Soo-Jin Kang, Jung-Min Ahn, Won-Jang Kim, Jong-Young Lee, Duk-Woo Park, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park and Seung-Jung Park
    ABSTRACT | Members CLICK HERE to Access Full Issue

     

    Metabolic syndrome does not impact long-term survival in patients with acute myocardial infarction after successful percutaneous coronary intervention with drug-eluting stents
    Ki-Bum Won, Byeong-Keuk Kim, Hyuk-Jae Chang, Dong-Ho Shin, Jung-Sun Kim, Young-Guk Ko, Donghoon Choi, Jong-Won Ha, Myeong-Ki Hong and Yangsoo Jang
    ABSTRACT | Members CLICK HERE to Access Full Issue

     

    Expert consensus statement on the use of fractional flow reserve, intravascular ultrasound, and optical coherence tomography: A consensus statement of the society of cardiovascular angiography and interventions
    Amir Lotfi, Allen Jeremias, William F. Fearon, Marc D. Feldman, Roxana Mehran, John C. Messenger, Cindy L. Grines, Larry S. Dean, Morton J. Kern and Lloyd W. Klein
    ABSTRACT | Members CLICK HERE to Access Full Issue

     

    Prevalence and management of coronary chronic total occlusions in a tertiary veterans affairs hospital
    Omar M. Jeroudi, Mohammed E. Alomar, Tesfaldet T. Michael, Abdallah El Sabbagh, Vishal G. Patel, Owen Mogabgab, Eric Fuh, Daniel Sherbet, Nathan Lo, Michele Roesle, Bavana V. Rangan, Shuaib M. Abdullah, Jeffrey L. Hastings, Jerrold Grodin, Subhash Banerjee and Emmanouil S. Brilakis
    ABSTRACT | Members CLICK HERE to Access Full Issue

     

    Predictors of high-risk angiographic findings in patients with non-st-segment elevation acute coronary syndrome
    Roy Beigel, Shlomi Matetzky, Natalie Gavrielov-Yusim, Paul Fefer, Shmuel Gottlieb, Doron Zahger, Shaul Atar, Ariel Finkelstein, Ariel Roguin, Ilan Goldenberg, Ran Kornowski and Amit Segev, ACSIS and ACSIS-PCI 2010 Investigators
    ABSTRACT | Members CLICK HERE to Access Full Issue

     

    Incidence of adverse cardiac events 5 years after polymer-free sirolimus eluting stent implantation: Results from the prospective Bad Berka Yukon Choice registry
    Marc-Alexander Ohlow, Hubertus von Korn, Oliver Gunkel, Ahmed Farah, Joerg T. Fuhrmann and Bernward Lauer
    ABSTRACT | Members CLICK HERE to Access Full Issue

     

    A prospective intravascular ultrasound investigation of the necessity for and efficacy of postdilation beyond nominal diameter of 3 current generation DES platforms for the percutaneous treatment of the left main coronary artery
    James A. Shand, Divyesh Sharma, Colm Hanratty, Anthony McClelland, Ian B.A. Menown, Mark S. Spence, Geoffrey Richardson, Niall A. Herity and Simon J. Walsh
    ABSTRACT | Members CLICK HERE to Access Full Issue

     

    Optical coherence tomography derived differences of plaque characteristics in coronary culprit lesions between type 2 diabetic patients with and without acute coronary syndrome
    Sebastian Reith, Simone Battermann, Rainer Hoffmann, Nikolaus Marx and Mathias Burgmaier
    ABSTRACT | Members CLICK HERE to Access Full Issue

     

    Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation
    Hae-Geun Song, Soo-Jin Kang, Jung-Min Ahn, Won-Jang Kim, Jong-Young Lee, Duk-Woo Park, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park and Seung-Jung Park
    ABSTRACT | Members CLICK HERE to Access Full Issue

     

    Early outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy: A European multicenter and multinational study
    Josef Veselka, Thorsten Lawrenz, Christoph Stellbrink, David Zemanek, Marian Branny, Jaroslav Januska, Jan Sitar, Pawel Dimitrow, Jan Krejci, Maciej Dabrowski, Stanislav Mizera, Thomas Bartel and Horst Kuhn
    ABSTRACT | Members CLICK HERE to Access Full Issue

     

    Initial experience with the glidesheath slender for transradial coronary angiography and intervention: A feasibility study with prospective radial ultrasound follow-up
    Adel Aminian, Dariouch Dolatabadi, Pascal Lefebvre, Robert Zimmerman, Philippe Brunner, Georges Michalakis and Jacques Lalmand
    ABSTRACT | Members CLICK HERE to Access Full Issue

    Back to Top


    FDA Issues Class 1 Recall of TorFlex Transseptal Guiding Sheath Kit

    The FDA has issued a Class 1 recall of TorFlex Transseptal Guiding Sheath Kit.

    The recall was issued because the sheath could remove particulate of less than 5 mm from the dilator. The particulate could potentially migrate into a patient’s bloodstream.  

    The TorFlex Transseptal Guiding Sheath Kit is a single use device designed for safe and easy catheterization and angiography of specific heart chambers and locations. The components of the device include a sheath, a dilator and a J-tipped guidewire. This recall covers 1,035 kits manufactured between 12/22/2011 and 07/24/2013. See list of affected lot numbers in Recall Notice.

    Customers are being instructed to examine their inventory and quarantine affected TorFlex Transseptal Guiding Sheath lots. Customers are then asked to sign and return a Medical Device Correction Acknowledgment Form directly to Baylis to their Fax number (905) 602-5671.

    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program: 

    • Complete and submit the report online: www.fda.gov/MedWatch/report.htm 
    • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

    Read the Complete MedWatch Safety Alert including links to the Recall Notice

    Back to Top


    Class 1 Recall of Edwards Lifesciences EMBOL-X Glide Protection System

    The FDA is notifying healthcare professionals that Edwards Lifesciences LLC issued a Class I Recall of the EMBOL-X Glide Protection System. The tip of the catheter is being recalled due to a deformed cannula tip. When force is applied to the tip during insertion or removal, it may lead to a separation and embolize. Use of this recalled product may cause serious adverse health consequences, including death.

    This recall includes model numbers EXGF24D, EXGF24LLD, EXGF24MMD, EXGF24SSD, EXGF24XLD, EXGF24XSD, EXGFXS2D, EXGF24SS2D, EXGF24MM2D, EXGF24LL2D and EXGF24XL2D. Edwards Lifesciences is recalling all lot numbers of the EMBOL-X Glide Protection System Cannulae that have not expired.

    Customers are being instructed to call Edwards Customer Service at 800-424-3278 from 6:00 AM – 4:30 PM Pacific Standard Time or contact your Edwards sales representative concerning this recall.
    Read the MedWatch safety alert, including a link to the Class I Recall notice, at:

    Read the MedWatch Safety Alert, Including a Link to the Class I Recall

    Back to Top


    Class 1 Recall Issued for Some Models of Medtronic Guidewires

    Based on an internal investigation following a limited number of complaints, including one patient injury, Medtronic began notifying hospitals and distributors worldwide the week of Oct. 21 that some models of its guidewires from recent lots have the potential for the coating on their surface to delaminate and detach. The notification requested that all potentially affected units be quarantined immediately and returned to the company as soon as possible for credit and replacement.

    Medtronic has also taken the necessary steps to prevent future shipments of the recalled products and notified regulatory agencies around the world as appropriate.

    The FDA defines a Class I recall as a situation in which there is a reasonable probability that use of, or exposure to, a violative product will cause serious adverse health consequences or death.

    The guidewires covered by this recall are designed to facilitate percutaneous coronary interventions or the placement of left ventricular leads for cardiac rhythm devices. They include specific lots from the following eight product lines that were manufactured after mid-April 2013:

    • Cougar nitinol workhorse guidewire
    • Cougar steerable guidewire
    • Zinger stainless steel workhorse guidewire
    • Zinger steerable guidewire
    • Thunder extra-support guidewire
    • Thunder steerable guidewire
    • ProVia crossing guidewire
    • Attain Hybrid guide wire

    Observations and consequences of the coating issue related to these guidewires should be reported to Medtronic in the United States by calling +1-877-526-7890 on weekdays from 8am to 5pm U.S. Central Time.

    Adverse reactions or quality problems experienced with the use of these products may be reported to the FDA Online or by calling 1-800-FDA-1088.

    Additional Information About the Recall

    Back to Top